Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
63.64
-2.58 (-3.90%)
At close: Jun 25, 2026, 4:00 PM EDT
63.64
0.00 (0.00%)
After-hours: Jun 25, 2026, 5:33 PM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$753,699
Market Cap
660.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| CorMedix | 191 |
| Rigel Pharmaceuticals | 174 |
| Aclaris Therapeutics | 73 |
| Oculis Holding AG | 60 |
| Candel Therapeutics | 55 |
| Faeth Therapeutics | 29 |
| Relmada Therapeutics | 17 |
DRUG News
- 22 days ago - Bright Minds Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - The Motley Fool
- 5 weeks ago - Bright Minds price target raised to $220 from $190 at Piper Sandler - TheFly
- 5 weeks ago - Bright Minds Biosciences Registration statement: Q2 2026 - Filings
- 5 weeks ago - Bright Minds Biosciences Registration statement: Q2 2026 - Filings
- 2 months ago - DRUG Initiates Coverage On Bright Minds Biosciences -- Price Target Announced - GuruFocus
- 2 months ago - Bright Minds initiated with a Buy at Jefferies - TheFly